DiscoverTreating Blood CancersHighlights from Attending ASH 2024
Highlights from Attending ASH 2024

Highlights from Attending ASH 2024

Update: 2025-01-17
Share

Description





Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

























Recorded on December 19, 2024











Lee Greenberger, PhD

Chief Scientific Officer and SVP

The Leukemia & Lymphoma Society

Rye Brook, NY









In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide information presented at the 66th American Society of Hematology (ASH) Annual Meeting, including updates in myeloma, leukemia, and lymphoma. Dr. Greenberger also discusses updates in blood cancer therapies, including nutrition, CAR T-cell therapy, and bispecifics. Tune in today!





















This episode is supported by Autolus Therapeutics.








Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Highlights from Attending ASH 2024

Highlights from Attending ASH 2024

Blood Cancer United